The Global Ischemic Heart Disease Market is expected to grow at a compound annual growth rate of 4.67% in the forecast period of 2021 to 2028 and is expected to reach USD 5,745.63 million by 2028. The high prevalence of chronic conditions such as diabetes, hypertension and cholesterol levels increasing the risk of suffering from cardiovascular diseases is significant factor bolstering the market growth rate.
Likewise, various product innovations along with the surge in the development of more advanced IHD drugs and government initiatives in the form of funding for diagnosis, treatment and research and their initiative programs to increase the awareness toward disease among the population will produce lucrative opportunities for the growth of the ischemic heart disease market.
Ischemic Heart Disease Market Scenario
According to Data Bridge Market Research the market for ischemic heart disease is expected to accelerate the market’s growth owing to the rising number of people suffering from IHD across the globe. Moreover, rise in mortality rate coupled with improving healthcare system, growth in population and increase in the occurrence of heart problems due to obesity and lack of physical activities is also expected to fuel the demand of the ischemic heart disease market over the forecast period of 2021 to 2028.
On the flip side, the factors such as high cost associated with the treatment and the regular uncertainty seen in reimbursement policies are expected to impede the growth of the ischemic heart disease market in the aforementioned forecast period. The rise in concerns regarding side effects on the body is projected to challenge the ischemic heart disease market in the forecast period of 2021-2028.
Now the question is which are the other regions that ischemic heart disease market is targeting? Data Bridge Market Research has estimated large growth in Asia-Pacific due to rising prevalence of heart diseases and strokes and increasing awareness towards CAD in the region.
For more analysis on the ischemic heart disease request for a briefing with our analysts https://www.databridgemarketresearch.com/fr/speak-to-analyst/?dbmr=global-ischemic-heart-disease-market
Ischemic Heart Disease Market Scope
Ischemic heart disease market is segmented on the basis of countries into the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
- All country based analysis of ischemic heart disease market is further analyzed based on maximum granularity into further segmentation. On the basis of disease, the ischemic heart disease market is segmented into angina pectoris and myocardial infarction. Angina pectoris is further segmented into stable angina, unstable angina and prinzmetal's angina. Myocardial infarction is further segmented into STEMI and NSTEMI. On the basis of drug class, the ischemic heart disease market is segmented into anti-dyslipidemic drugs, calcium channel blockers, beta-blockers, ACE inhibitors, ARBs, vasodilators and antithrombotic agents.
- Ischemic heart disease also referred as IHD is basically an abnormal condition of the heart which is caused by narrowed heart arteries which results in less blood and oxygen supply to the heart muscle, which buildups plaque in the arteries. The lack of sufficient blood supply might result in recurrent chest pain and discomfort leading to a condition called angina pectoris.
To know more about the study, https://www.databridgemarketresearch.com/fr/reports/global-ischemic-heart-disease-market
Key Pointers Covered in the Ischemic Heart Disease Market Industry Trends and Forecast to 2028
- Market Size
- Market New Sales Volumes
- Market Replacement Sales Volumes
- Market Installed Base
- Market By Brands
- Market Procedure Volumes
- Market Product Price Analysis
- Market Healthcare Outcomes
- Market Cost of Care Analysis
- Market Regulatory Framework and Changes
- Prices and Reimbursement Analysis
- Market Shares in Different Regions
- Recent Developments for Market Competitors
- Market Upcoming Applications
- Market Innovators Study
Key Market Competitors Covered in the Report
- Amgen Inc.
- AstraZeneca
- Bayer AG
- Novartis AG
- Gilead Sciences, Inc
- GlaxoSmithKline plc
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- Cardurion Pharmaceuticals
- Cardior Pharmaceuticals
- Actelion Pharmaceuticals Ltd
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- CYTOKINETICS, INC
- Eli Lilly and Company
- Merck Sharp & Dohme Corp
- Quantum Genomics
- RENOVA
- SERVIER LABORATORIES
- Stealth BioTherapeutics Inc
- Sanofi
- Mylan N.V
- Bausch Health Companies Inc.
Above are the key players covered in the report, to know about more and exhaustive list of ischemic heart disease companies’ contact us https://www.databridgemarketresearch.com/fr/toc/?dbmr=global-ischemic-heart-disease-market
Research Methodology of Global Ischemic Heart Disease Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Related Reports
- Global Wearable Heart Monitoring Devices Market - Industry Trends and Forecast to 2028
- Global Prosthetic Heart Valve Market - Industry Trends and Forecast to 2028
- Global Heart Pump Devices Market - Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/fr/report-category/healthcare/
